Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
63,440,286
-
Share change
-
-311,863
-
Total reported value
-
$5,097,858,541
-
Put/Call ratio
-
95%
-
Price per share
-
$80.36
-
Number of holders
-
251
-
Value change
-
-$70,715,291
-
Number of buys
-
122
-
Number of sells
-
139
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q3 2015
As of 30 Sep 2015,
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by
251 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,440,286 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Capital World Investors, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., FIRST TRUST ADVISORS LP, STATE STREET CORP, GILDER GAGNON HOWE & CO LLC, and JENNISON ASSOCIATES LLC.
This page lists
251
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.